Literature DB >> 29435075

BRCA1 homozygous unclassified variant in a patient with non-Fanconi anemia: A case report.

Davide Bondavalli1, Francesca Malvestiti2, Valeria Pensotti3,4, Irene Feroce1, Bernardo Bonanni1.   

Abstract

The present case report discusses a woman affected by chronic lymphatic leukemia and breast cancer with a familial history of breast cancer; suspected to be hereditary breast and ovarian cancer (HBOC) syndrome. The patient underwent BRCA1 and BRCA2 genetic testing. Sequencing of BRCA1 revealed the presence of the variant of unknown significance (VUS) c.3082C>T (p.Arg1028Cys) at homozygous state, whereas no mutations were detected in BRCA2. Multiplex ligation-dependent probe amplification confirmed the presence of two alleles. Although consanguineity between her parents was reported, which therefore supported the molecular data, her clinical phenotype was not suggestive of typical Fanconi anemia (FA), particularly of a BRCA1-linked FA. In the two cases reported in the literature, carriers of biallelic BRCA1 mutation present a severe and quite typical phenotype. For this reason, the patient was offered a diepoxybutane test, where neither complex rearrangements nor multiradial formation were detected. We were therefore inclined to consider that BRCA1 VUS as of little clinical significance.

Entities:  

Keywords:  Fanconi anemia; diepoxybutane test; hereditary breast and ovarian cancer syndrome; homozygous BRCA1; p.Arg1028Cys

Year:  2017        PMID: 29435075      PMCID: PMC5778837          DOI: 10.3892/ol.2017.7711

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  11 in total

Review 1.  Variants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.

Authors:  Susan Miller-Samuel; Deborah J MacDonald; Deborah J McDonald; Jeffrey N Weitzel; Ferdy Santiago; Martin A Martino; Tara Namey; Annmarie Augustyn; Rebecca Mueller; Andrea Forman; Angela R Bradbury; Gloria J Morris
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

2.  A human BRCA1 gene knockout.

Authors:  M Boyd; F Harris; R McFarlane; H R Davidson; D M Black
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

3.  Fanconi anemia diagnosis and the diepoxybutane (DEB) test.

Authors:  A D Auerbach
Journal:  Exp Hematol       Date:  1993-06       Impact factor: 3.084

4.  Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method.

Authors:  A D Auerbach; B Adler; R S Chaganti
Journal:  Pediatrics       Date:  1981-01       Impact factor: 7.124

Review 5.  How I manage patients with Fanconi anaemia.

Authors:  Carlo Dufour
Journal:  Br J Haematol       Date:  2017-05-05       Impact factor: 6.998

6.  Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.

Authors:  Sarah L Sawyer; Lei Tian; Marketta Kähkönen; Jeremy Schwartzentruber; Martin Kircher; Jacek Majewski; David A Dyment; A Micheil Innes; Kym M Boycott; Lisa A Moreau; Jukka S Moilanen; Roger A Greenberg
Journal:  Cancer Discov       Date:  2014-12-03       Impact factor: 39.397

Review 7.  Fanconi anemia and its diagnosis.

Authors:  Arleen D Auerbach
Journal:  Mutat Res       Date:  2009-02-28       Impact factor: 2.433

8.  Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humans.

Authors:  Angela Burk-Herrick; Mark Scally; Heather Amrine-Madsen; Michael J Stanhope; Mark S Springer
Journal:  Mamm Genome       Date:  2006-03-03       Impact factor: 2.957

9.  Meta-analysis of BRCA1 and BRCA2 penetrance.

Authors:  Sining Chen; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

10.  Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases.

Authors:  Paris J Vail; Brian Morris; Aric van Kan; Brianna C Burdett; Kelsey Moyes; Aaron Theisen; Iain D Kerr; Richard J Wenstrup; Julie M Eggington
Journal:  J Community Genet       Date:  2015-03-18
View more
  1 in total

1.  Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).

Authors:  Lisa J McReynolds; Kajal Biswas; Neelam Giri; Shyam K Sharan; Blanche P Alter
Journal:  Cancer Genet       Date:  2021-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.